+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Postpartum Depression Drug"

Postpartum Depression - Pipeline Insight, 2024 - Product Thumbnail Image

Postpartum Depression - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Postpartum Depression Global Market Report 2024 - Product Thumbnail Image

Postpartum Depression Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Postpartum Depression - Epidemiology Forecast to 2032 - Product Thumbnail Image

Postpartum Depression - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

The Postpartum Depression Drug market is a subset of the Mental Disorders Drugs market. Postpartum depression is a type of depression that can occur in women after childbirth. It is estimated to affect up to 20% of women after giving birth. Postpartum depression drugs are used to treat the symptoms of postpartum depression, such as sadness, anxiety, and fatigue. These drugs are typically prescribed by a doctor and can include antidepressants, psychotherapy, and hormone therapy. The Postpartum Depression Drug market is a growing market, with an increasing number of women being diagnosed with postpartum depression. The market is expected to continue to grow as more women seek treatment for postpartum depression. Some companies in the Postpartum Depression Drug market include Eli Lilly, Pfizer, GlaxoSmithKline, and Johnson & Johnson. Show Less Read more